11，Sheng HG,Shao JY,Kirkland SC,et al.Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.J Clin Invest.1997,99:2254
22 Hawkey CJ.COX-2 Inhibitors.Lancet 1999,353:307
33，Warner TD,Giulianl F,Vojnovic I,et al.Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity:A full in vitro analysis.Proc Natl Acad Sci USA 1999,96:7563
44，Babb RR.Gastrointestinal complication of non-steriod anti-inflammatory drugs.West J Med 1992,157:444
55，Sandler RS,Galanko JC,Murray SC,et al.Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.Gastroenterolog 1998,114:441
66 Pincus T,Griffin M.Gastrointestinal disease associated with non-steriod anti-inflammatory drugs.Am J Med 1991,91:209
77，Bollini P,Rodriguez LA,Gutthann Sp.The impact of research quality and study design on epidemiologic estimates of effects of non-steriod anti-inflammatory drugs on upper gastrointestinal disease.Arch Intern Med 1992,152:1289
88，Zeidler H.Epidemiologicy of NSAID induced gastropathy. Clin Rheumatol 1991,10:36
99，Shankel SW,Jonhson DC,Clark PS,et al.Acute renal failure and glomerulopathy caused by non-steriod anti-inflammatory drugs.Arch Intern Med 1992,152:986
1010，Stillman MT,Schleginger PA.Non-steriod anti-inflammatory drug nephrotoxicity.Arch Intern Med 1990,150:268
